Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Commercial launch of INPEFA® continues to progress. with increasing demand across the cardiology community and improving payer access Patient enrollment underway in PROGRESS, a Phase 2b study of...
Source: marketscreener.com